The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-055: A phase II trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and cetuximab.
 
Steven Francis Powell
No Relationships to Disclose
 
Stephen V. Liu
Consulting or Advisory Role - Biodesix; Genentech; Perthera
 
Ammar Sukari
Consulting or Advisory Role - Bayer
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Bayer; Merck; Novartis
 
Christine H. Chung
Consulting or Advisory Role - Novartis
Research Funding - Boehringer Ingelheim; Immunogen
Travel, Accommodations, Expenses - Merck
 
Joshua Bauml
Research Funding - Merck
 
Robert I. Haddad
Consulting or Advisory Role - Bayer; Celgene
Research Funding - Boehringer Ingelheim (Inst)
 
Christine K. Gause
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michelle Niewood
Employment - Incyte; Merck
 
Linda L. Gammage
Employment - Merck
 
Holly Brown
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Amy Meister
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan D. Cheng
Employment - Merck Sharp & Dohme
Leadership - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Mark M. Gitau
No Relationships to Disclose